from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1269c/-

LFCtreatmentdescriptionclass of inhibitor

0.535

Amikacinug/mL Amikacintranslation

-0.195

Cap5-10ug/mL Capreomycintranslation

-0.443

Rox10-50 ug/mL Roxithromycintranslation

-0.140

SM2-5 ug/mL Streptomycintranslation

0.241

Tet5-10 ug/mL Tetracyclinetranslation

0.477

Rif0.2-5ug/mL Rifampicintranscription

0.260

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.563

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.632

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.578

CPZ10-50 ug/mL Chlorpromazinerespiration

1.484

Clofazimine10-13 ug/mL Clofaziminerespiration

1.313

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.750

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.255

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.389

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.231

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.235

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.103

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.234

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.503

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.437

KCN5-20 ug/mL Potassium cyaniderespiration

2.219

NaN30.2-2 mM Sodium aziderespiration

-1.247

Nigericin50 uM Nigericinrespiration

0.235

TRC10-150 ug/mL Triclosanrespiration

1.594

TRZ10-25 ug/mL Thioridazinerespiration

-1.205

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.979

menadione6-10 ug/mL Menadionerespiration

0.349

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.167

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.269

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.139

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.099

NRP_1Non-replicating persistence stage 1dosRassociated

-0.441

Amp0.2mg/mL AmpicillincellWall

-0.050

Cephalexin20-100 ug/mL CephalexincellWall

-0.308

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.277

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.355

EMB10-20 ug/mL EthambutolcellWall

-0.488

Eta12-40 ug/mL EthionamidecellWall

-0.736

INH0.2-0.4 ug/mL IsoniazidcellWall

0.002

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.124

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.426

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.425

BZA0.12 mg/mL BenzamidearomaticAmides

0.132

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.035

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.006

H2O24 mM hydrogen peroxideDNAdamaging

-0.033

Levo10 ug/mL LevofloxacinDNAdamaging

-0.344

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.246

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.022

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.333

UVUV-irradiationDNAdamaging

0.085

ARP41-4 ug/mL Antitubercular compound ARP4?

0.316

Antimycin12.5-50 ug/mL Antimycin A?

-0.786

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.391

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.047

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.773

PA8240.2-2 ug/mL PA-824?

-1.400

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.220

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.445

Verapamil50 uM Verapamil?

-0.487

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.436

methoxatin10-20 ug/mL Methoxatin?